gefitinib has been researched along with incb3619 in 2 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (incb3619) | Trials (incb3619) | Recent Studies (post-2010) (incb3619) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 9 | 0 | 5 |
| Protein | Taxonomy | gefitinib (IC50) | incb3619 (IC50) |
|---|---|---|---|
| Disintegrin and metalloproteinase domain-containing protein 10 | Homo sapiens (human) | 0.0312 | |
| Disintegrin and metalloproteinase domain-containing protein 17 | Sus scrofa (pig) | 0.014 | |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 0.068 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 0.037 | |
| Stromelysin-1 | Homo sapiens (human) | 3.78 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 0.366 | |
| Macrophage metalloelastase | Homo sapiens (human) | 0.017 | |
| Matrix metalloproteinase-14 | Homo sapiens (human) | 0.772 | |
| Disintegrin and metalloproteinase domain-containing protein 8 | Homo sapiens (human) | 1 | |
| Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) | 0.507 | |
| Disintegrin and metalloproteinase domain-containing protein 33 | Homo sapiens (human) | 1.026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dreymuller, D; Fields, GB; Fridman, R; Giulianotti, M; Golubkov, V; Houghten, RA; Knapinska, AM; LaVoi, TM; Ludwig, A; Minond, D; Smith, L; Sohail, A | 1 |
| Baribaud, F; Caudler, E; Fridman, JS; Friedman, SM; Gazdar, AF; Girard, L; He, B; Jablons, DM; Li, Y; Liu, C; Lo, Y; Mikami, I; Minna, JD; Newton, RC; Peyton, M; Reguart, N; Scherle, PA; Vaddi, K; Yang, G; Yao, W; Zhou, BB | 1 |
2 other study(ies) available for gefitinib and incb3619
| Article | Year |
|---|---|
SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.
Topics: ADAM Proteins; ADAM17 Protein; Animals; Cell Line; CHO Cells; Cricetinae; Cricetulus; Humans; In Vitro Techniques; Molecular Probes; Structure-Activity Relationship; Substrate Specificity | 2015 |
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer.
Topics: ADAM Proteins; ADAM17 Protein; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; ErbB Receptors; Female; Gefitinib; Gene Expression; Humans; Ligands; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Paclitaxel; Piperidines; Protease Inhibitors; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-3; Signal Transduction; Spiro Compounds; Xenograft Model Antitumor Assays | 2006 |